ARK Invest's position in TXG, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| ARKK | 2,912,436 | $172.1M | 2.36% | #18 |
| ARKG | 2,629,521 | $155.4M | 7.87% | #2 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-06 | ARKK | Buy | Added | 14,605 | $866K |
| 2026-11-05 | ARKK | Buy | Added | 80,036 | $4.6M |
| 2026-10-29 | ARKK | Sell | Trimmed | 6,924 | $565K |
| 2026-10-28 | ARKK | Sell | Trimmed | 48,140 | $4.0M |
| 2026-10-14 | ARKK | Sell | Trimmed | 113,555 | $8.3M |
| 2026-10-08 | ARKK | Sell | Trimmed | 237,109 | $18.3M |
| 2026-10-06 | ARKK | Sell | Trimmed | 9,826 | $793K |
| 2026-10-06 | ARKG | Sell | Trimmed | 13,677 | $1.1M |
| 2026-10-05 | ARKG | Sell | Trimmed | 27,277 | $2.7M |
| 2026-10-02 | ARKG | Sell | Trimmed | 12,115 | $1.1M |
| 2026-09-29 | ARKK | Sell | Trimmed | 386,216 | $34.8M |
| 2026-09-29 | ARKG | Sell | Trimmed | 49,178 | $4.4M |
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables,…
See TXG's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open TXG on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.